(Q37416125)

20 August 2017

1 reference

title

Cutaneous leishmaniasis: disease susceptibility and pharmacogenetic implications (English)

1 reference

20 August 2017

main subject

cutaneous leishmaniasis

1 reference

Mahreen Ameen

1

1 reference

20 August 2017

publication date

1 March 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

451-461

1 reference

Leishmaniasis: current situation and new perspectives

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

The increase in risk factors for leishmaniasis worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: ‘bringing down the neighbourhood’

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Old world leishmaniasis: an emerging infection among deployed US military and civilian workers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Spread of vector-borne diseases and neglect of Leishmaniasis, Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

T-cell and cytokine responses in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

The immunology of susceptibility and resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

T helper (h)1/Th2 and Leishmania: paradox rather than paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Cytokine patterns in the pathogenesis of human leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Leishmania major LACK antigen is required for efficient vertebrate parasitization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Post-kala-azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Mucosal leishmaniasis ("espundia" Escomel, 1911).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Advances in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Cutaneous leishmaniasis: therapeutic strategies and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Mucosal leishmaniasis . Current scenario and prospects for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Treatment of cutaneous leishmaniasis among travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Recent advances in vaccines for leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

The genome of the kinetoplastid parasite, Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Cutaneous leishmaniasis in Al-Hassa, Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Clinical manifestations of cutaneous leishmaniasis in Sri Lanka - possible evidence for genetic susceptibility among the Sinhalese

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Human cutaneous leishmaniasis caused by Leishmania donovani s.l. in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Human cutaneous leishmaniasis caused by Leishmania donovani sensu stricto in Yemen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Leishmania donovani leishmaniasis in Cyprus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetic epidemiology of visceral leishmaniasis in northeastern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genes and susceptibility to leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetics of murine leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Role of HLA class II alleles in susceptibility to and protection from localized cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Tumor necrosis factor (cachectin) in human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

IL-4-deficient Balb/c mice resist infection with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Up-regulation of Th1-type responses in mucosal leishmaniasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

A Major Susceptibility Locus on Chromosome 22q12 Plays a Critical Role in the Control of Kala-Azar

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

SLC11A1 (formerly NRAMP1) and disease resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Genetic dissection of immunity to mycobacteria: the human model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Interleukin-10 and the pathogenesis of human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Comparative genomic analysis of three Leishmania species that cause diverse human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

Comparative genomics: from genotype to disease phenotype in the leishmaniases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

From genome to vaccines for leishmaniasis: Screening 100 novel vaccine candidates against murine Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.451

10.2217/14622416.10.3.451

21 January 2018

Identifiers

DOI

1 reference

release_sudflpeq7rbg3aiqqemfezocoq

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sudflpeq7rbg3aiqqemfezocoq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference